Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Core Laboratories Inc.

Stage 4 · Declining · week 3

As of Oct 22, 2026, Core Laboratories is in Stage 4, the downtrend phase, now in week 3 (since Oct 5, 2026). It closed at $9.40, 52.1% below its 52-week high and below its 200-day average, which is falling.

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. More about the company

$9.40
-7.30% today
$431M · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is CLB early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 21w
S4 24w
S2 19w
S4 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 8w → S3 4w → S4 21w → S1 13w → S2 9w → S3 9w → S2 7w → S3 4w → S4 24w → S1 3w → S4 7w → S1 6w → S2 19w → S3 10w → S4 14w → S1 3w → S4 3w current
Total tracked: 165 weeks across 17 stage runs.

CLB among Oil & Gas Equipment & Services40th of 49 by relative strength

All 49 →
Stocks in Oil & Gas Equipment & Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1FETStage 2 · wk 1198−1.4%
2SNDStage 2 · wk 797−6.3%
3STAKStage 4 · wk 396+77.7%
4EFXTStage 2 · wk 295−1.0%
5FTIStage 3 · wk 293−6.2%
6TSStage 2 · wk 191+1.1%
7NESRStage 3 · wk 291−40.2%
8TDWStage 2 · wk 1091−7.3%
…40CLBStage 4 · wk 338−11.6%
vs 52W High
-52.1%
$9.40 lo$19.63 hi
52.1% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 3
1w13w26w
Week 3, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-33.4%
200 DMA: $14.10 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.81x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-11.6%
3M
-19.4%
6M
-44.8%
YTD
-44.4%
1Y
-21.7%
Scan Membership
Breakout Watch
Latest: 2024-11-13
7 appearances in last 60 days. First seen: 2020-12-10.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 3 · Vol 1.81x
2026-10-21S4
Wk 3 · Vol 0.71x
2026-10-20S4
Wk 3 · Vol 0.66x
2026-10-19S4
Wk 3 · Vol 0.83x
2026-10-16S4
Wk 2 · Vol 0.68x
2026-10-15S4
Wk 2 · Vol 1.43x
2026-10-14S4
Wk 2 · Vol 1.25x
2026-10-13S4
Wk 2 · Vol 1.33x
2026-10-12S4
Wk 2 · Vol 0.76x
2026-10-09S4
Wk 1 · Vol 1.06x
2026-10-08S4
Wk 1 · Vol 0.87x
2026-10-07S4
Wk 1 · Vol 0.99x
Moving averages & range
50 DMA
$11.25
200 DMA
$14.10
52W High
$19.63
52W Low
$9.40
5D Low
$9.40
Resistance levels (recent highs)
20d High
$10.51
60d High
$12.65
120d High
$14.53
250d High
$19.63
Next resistance
+11.8%
to 20d High
P/E (TTM)
18.1
Forward 13.6
Earnings Growth (YoY)
-41.2%
Revenue -4.3%
ROE
+9.0%
Profit margin +4.7%
Dividend Yield
0.39%
P/B 1.6

Core Laboratories: quick answers

What stage is Core Laboratories in?

As of Oct 22, 2026, Core Laboratories (CLB) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 5, 2026 and is in week 3. What the four stages mean

Is Core Laboratories in an uptrend?

No. Core Laboratories is in a Stage 4 downtrend. It trades 33.4% below its 200-day average, which is falling.

How far is Core Laboratories from its 52-week high?

Core Laboratories closed at $9.40 on Oct 22, 2026, 52.1% below its 52-week high of $19.63. Its 52-week low is $9.40.

How has Core Laboratories performed over the past year?

As of Oct 22, 2026, Core Laboratories is down 21.7% over the past year and down 44.4% so far in 2026.

Which sector and industry is Core Laboratories in?

Core Laboratories is in the Oil & Gas Equipment & Services industry, part of the Energy sector.

About this companyEnergy· Oil & Gas Equipment & Services

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.